Yersinia pestis Activates Both IL-1β and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague

被引:26
|
作者
Sivaraman, Vijay [1 ,2 ]
Pechous, Roger D. [1 ]
Stasulli, Nikolas M. [1 ]
Miao, Edward A. [1 ]
Goldman, William E. [1 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA
[2] N Carolina Cent Univ, Dept Biol, Durham, NC USA
基金
美国国家卫生研究院;
关键词
CASPASE-1; ACTIVATION; IMMUNE-RESPONSES; SECRETION; INNATE; VIRULENCE; RECOGNITION; MACROPHAGES; PATHOLOGY; PROTEIN; INJURY;
D O I
10.1371/journal.ppat.1004688
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pneumonic plague is the most rapid and lethal form of Yersinia pestis infection. Increasing evidence suggests that Y. pestis employs multiple levels of innate immune evasion and/or suppression to produce an early "pre-inflammatory" phase of pulmonary infection, after which the disease is highly inflammatory in the lung and 100% fatal. In this study, we show that IL-1 beta/IL-18 cytokine activation occurs early after bacteria enter the lung, and this activation eventually contributes to pulmonary inflammation and pathology during the later stages of infection. However, the inflammatory effects of IL-1 beta/IL-1-receptor ligation are not observed during this first stage of pneumonic plague. We show that Y. pestis also activates the induction of IL-1 receptor antagonist (IL-1RA), and this activation likely contributes to the ability of Y. pestis to establish the initial pre-inflammatory phase of disease.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [1] Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation
    Palmer, Gaby
    Talabot-Ayer, Dominique
    Kaya, Guerkan
    Gabay, Cem
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (08) : 1938 - 1946
  • [2] IL-1 receptor antagonist as an aerosol in inflammation
    Ischenko, Alexander M.
    Nikolaev, Boris P.
    Kotova, Tatiana V.
    Vorobeychikov, Eugeny V.
    Konusova, Velentina G.
    Yakovleva, Ludmila Y.
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2007, 20 (04): : 445 - 459
  • [3] Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental shigellosis
    Arondel, J
    Singer, M
    Matsukawa, A
    Zychlinsky, A
    Sansonetti, PJ
    INFECTION AND IMMUNITY, 1999, 67 (11) : 6056 - 6066
  • [4] Roles of IL-1 and IL-1 receptor antagonist in the immune system
    Horai, R
    Asano, M
    Nakae, S
    Saijo, S
    Sudo, K
    Iwakura, Y
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 380 - 380
  • [5] The IL-1 system in HIV infection: Peripheral concentrations of IL-1 beta, IL-1 receptor antagonist and soluble IL-1 receptor type II
    Kreuzer, KA
    Dayer, JM
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 54 - 58
  • [6] Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers
    Joos, L
    McIntyre, L
    Ruan, J
    Connett, JE
    Anthonisen, NR
    Weir, TD
    Paré, PD
    Sandford, AJ
    THORAX, 2001, 56 (11) : 863 - 866
  • [7] Mechanical deformation promotes secretion of IL-1α and IL-1 receptor antagonist
    Lee, RT
    Briggs, WH
    Cheng, GC
    Rossiter, HB
    Libby, P
    Kupper, T
    JOURNAL OF IMMUNOLOGY, 1997, 159 (10): : 5084 - 5088
  • [8] Polymorphisms in IL-1β and IL-1 receptor antagonist associated with myasthenia gravis
    Huang, D
    Pirskanen, R
    Hjelmström, P
    Lefvert, AK
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 81 (1-2) : 76 - 81
  • [9] Immunohistochemical staining of IL-1 alpha and IL-1 receptor antagonist but not IL-1 beta in cultures of Sertoli cells
    Huleihel, M
    Zeyse, D
    Lunenfeld, E
    Beck, M
    Prinsloo, I
    Potashnik, G
    Mazor, M
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 45 (03) : 135 - 141
  • [10] IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1β genes
    Hurme, M
    Santtila, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (08) : 2598 - 2602